カテゴリー： QYResearch, 世界

世界の特発性肺線維症薬市場 2019年

【英語タイトル】Global Idiopathic Pulmonary Fibrosis Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X09542）・商品コード：DATA909X09542
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：食品・飲料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、特発性肺線維症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルココルチコイド、免疫抑制剤、その他に、用途別には、病院、診療所、その他にセグメント区分し、特発性肺線維症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・特発性肺線維症薬の世界市場概要
・特発性肺線維症薬の製造コスト構成分析
・特発性肺線維症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・特発性肺線維症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・特発性肺線維症薬のセグメント分析（種類別）
（グルココルチコイド、免疫抑制剤、その他）
・特発性肺線維症薬のセグメント分析（用途別）
（病院、診療所、その他）
・特発性肺線維症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Roche、Boehringer Ingelheim、Beijing Continent Pharmaceutical、Cipla、Shionogi、）
・特発性肺線維症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Idiopathic Pulmonary Fibrosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Idiopathic Pulmonary Fibrosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Idiopathic Pulmonary Fibrosis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Idiopathic Pulmonary Fibrosis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Idiopathic Pulmonary Fibrosis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Boehringer Ingelheim
Beijing Continent Pharmaceutical
Cipla
Shionogi
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Glucocorticoid
Immunosuppressive Agent
Others

Segment by Application
Hospital
Clinic
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Idiopathic Pulmonary Fibrosis Drug
1.1 Definition of Idiopathic Pulmonary Fibrosis Drug
1.2 Idiopathic Pulmonary Fibrosis Drug Segment by Type
1.2.1 Global Idiopathic Pulmonary Fibrosis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Glucocorticoid
1.2.3 Immunosuppressive Agent
1.2.4 Others
1.3 Idiopathic Pulmonary Fibrosis Drug Segment by Applications
1.3.1 Global Idiopathic Pulmonary Fibrosis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Idiopathic Pulmonary Fibrosis Drug Overall Market
1.4.1 Global Idiopathic Pulmonary Fibrosis Drug Revenue (2014-2025)
1.4.2 Global Idiopathic Pulmonary Fibrosis Drug Production (2014-2025)
1.4.3 North America Idiopathic Pulmonary Fibrosis Drug Status and Prospect (2014-2025)
1.4.4 Europe Idiopathic Pulmonary Fibrosis Drug Status and Prospect (2014-2025)
1.4.5 China Idiopathic Pulmonary Fibrosis Drug Status and Prospect (2014-2025)
1.4.6 Japan Idiopathic Pulmonary Fibrosis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Status and Prospect (2014-2025)
1.4.8 India Idiopathic Pulmonary Fibrosis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Idiopathic Pulmonary Fibrosis Drug
2.3 Manufacturing Process Analysis of Idiopathic Pulmonary Fibrosis Drug
2.4 Industry Chain Structure of Idiopathic Pulmonary Fibrosis Drug

3 Development and Manufacturing Plants Analysis of Idiopathic Pulmonary Fibrosis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Idiopathic Pulmonary Fibrosis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Idiopathic Pulmonary Fibrosis Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Idiopathic Pulmonary Fibrosis Drug Production and Capacity Analysis
4.2 Idiopathic Pulmonary Fibrosis Drug Revenue Analysis
4.3 Idiopathic Pulmonary Fibrosis Drug Price Analysis
4.4 Market Concentration Degree

5 Idiopathic Pulmonary Fibrosis Drug Regional Market Analysis
5.1 Idiopathic Pulmonary Fibrosis Drug Production by Regions
5.1.1 Global Idiopathic Pulmonary Fibrosis Drug Production by Regions
5.1.2 Global Idiopathic Pulmonary Fibrosis Drug Revenue by Regions
5.2 Idiopathic Pulmonary Fibrosis Drug Consumption by Regions
5.3 North America Idiopathic Pulmonary Fibrosis Drug Market Analysis
5.3.1 North America Idiopathic Pulmonary Fibrosis Drug Production
5.3.2 North America Idiopathic Pulmonary Fibrosis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Idiopathic Pulmonary Fibrosis Drug Import and Export
5.4 Europe Idiopathic Pulmonary Fibrosis Drug Market Analysis
5.4.1 Europe Idiopathic Pulmonary Fibrosis Drug Production
5.4.2 Europe Idiopathic Pulmonary Fibrosis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Idiopathic Pulmonary Fibrosis Drug Import and Export
5.5 China Idiopathic Pulmonary Fibrosis Drug Market Analysis
5.5.1 China Idiopathic Pulmonary Fibrosis Drug Production
5.5.2 China Idiopathic Pulmonary Fibrosis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Idiopathic Pulmonary Fibrosis Drug Import and Export
5.6 Japan Idiopathic Pulmonary Fibrosis Drug Market Analysis
5.6.1 Japan Idiopathic Pulmonary Fibrosis Drug Production
5.6.2 Japan Idiopathic Pulmonary Fibrosis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Idiopathic Pulmonary Fibrosis Drug Import and Export
5.7 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Market Analysis
5.7.1 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Production
5.7.2 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Import and Export
5.8 India Idiopathic Pulmonary Fibrosis Drug Market Analysis
5.8.1 India Idiopathic Pulmonary Fibrosis Drug Production
5.8.2 India Idiopathic Pulmonary Fibrosis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Idiopathic Pulmonary Fibrosis Drug Import and Export

6 Idiopathic Pulmonary Fibrosis Drug Segment Market Analysis (by Type)
6.1 Global Idiopathic Pulmonary Fibrosis Drug Production by Type
6.2 Global Idiopathic Pulmonary Fibrosis Drug Revenue by Type
6.3 Idiopathic Pulmonary Fibrosis Drug Price by Type

7 Idiopathic Pulmonary Fibrosis Drug Segment Market Analysis (by Application)
7.1 Global Idiopathic Pulmonary Fibrosis Drug Consumption by Application
7.2 Global Idiopathic Pulmonary Fibrosis Drug Consumption Market Share by Application (2014-2019)

8 Idiopathic Pulmonary Fibrosis Drug Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche Idiopathic Pulmonary Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
8.2.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.2.3 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Beijing Continent Pharmaceutical
8.3.1 Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
8.3.2 Beijing Continent Pharmaceutical Product Introduction, Application and Specification
8.3.3 Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cipla
8.4.1 Cipla Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
8.4.2 Cipla Product Introduction, Application and Specification
8.4.3 Cipla Idiopathic Pulmonary Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Shionogi
8.5.1 Shionogi Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
8.5.2 Shionogi Product Introduction, Application and Specification
8.5.3 Shionogi Idiopathic Pulmonary Fibrosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Idiopathic Pulmonary Fibrosis Drug Market
9.1 Global Idiopathic Pulmonary Fibrosis Drug Market Trend Analysis
9.1.1 Global Idiopathic Pulmonary Fibrosis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Idiopathic Pulmonary Fibrosis Drug Regional Market Trend
9.2.1 North America Idiopathic Pulmonary Fibrosis Drug Forecast 2019-2025
9.2.2 Europe Idiopathic Pulmonary Fibrosis Drug Forecast 2019-2025
9.2.3 China Idiopathic Pulmonary Fibrosis Drug Forecast 2019-2025
9.2.4 Japan Idiopathic Pulmonary Fibrosis Drug Forecast 2019-2025
9.2.5 Southeast Asia Idiopathic Pulmonary Fibrosis Drug Forecast 2019-2025
9.2.6 India Idiopathic Pulmonary Fibrosis Drug Forecast 2019-2025
9.3 Idiopathic Pulmonary Fibrosis Drug Market Trend (Product Type)
9.4 Idiopathic Pulmonary Fibrosis Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Idiopathic Pulmonary Fibrosis Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Idiopathic Pulmonary Fibrosis Drug
Table Global Idiopathic Pulmonary Fibrosis Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Idiopathic Pulmonary Fibrosis Drug Production Market Share by Types in 2018
Figure Glucocorticoid Product Picture
Figure Immunosuppressive Agent Product Picture
Figure Others Product Picture
Table Global Idiopathic Pulmonary Fibrosis Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Idiopathic Pulmonary Fibrosis Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Other
Figure Global Idiopathic Pulmonary Fibrosis Drug Revenue (Million USD) (2014-2025)
Figure Global Idiopathic Pulmonary Fibrosis Drug Production (K Pcs) (2014-2025)
Figure North America Idiopathic Pulmonary Fibrosis Drug Market Size (Million USD) (2014-2025)
Figure Europe Idiopathic Pulmonary Fibrosis Drug Market Size (Million USD) (2014-2025)
Figure China Idiopathic Pulmonary Fibrosis Drug Market Size (Million USD) (2014-2025)
Figure Japan Idiopathic Pulmonary Fibrosis Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Drug Market Size (Million USD) (2014-2025)
Figure India Idiopathic Pulmonary Fibrosis Drug Market Size (Million USD) (2014-2025)
Table Idiopathic Pulmonary Fibrosis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Idiopathic Pulmonary Fibrosis Drug in 2018
Figure Manufacturing Process Analysis of Idiopathic Pulmonary Fibrosis Drug
Figure Industry Chain Structure of Idiopathic Pulmonary Fibrosis Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Idiopathic Pulmonary Fibrosis Drug Manufacturing Plants Distribution
Table Idiopathic Pulmonary Fibrosis Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Idiopathic Pulmonary Fibrosis Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Idiopathic Pulmonary Fibrosis Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Idiopathic Pulmonary Fibrosis Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Idiopathic Pulmonary Fibrosis Drug Production Share by Manufacturers in 2018
Table Idiopathic Pulmonary Fibrosis Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Idiopathic Pulmonary Fibrosis Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Idiopathic Pulmonary Fibrosis Drug Revenue Share by Manufacturers in 2018
Table Idiopathic Pulmonary Fibrosis Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Idiopathic Pulmonary Fibrosis Drug Production by Regions 2014-2019 (K Pcs)
Table Global Idiopathic Pulmonary Fibrosis Drug Production Market Share by Regions 2014-2019
Figure Global Idiopathic Pulmonary Fibrosis Drug Production Market Share by Regions in 2018
Table Global Idiopathic Pulmonary Fibrosis Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Idiopathic Pulmonary Fibrosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Idiopathic Pulmonary Fibrosis Drug Revenue Market Share by Regions in 2018
Table Global Idiopathic Pulmonary Fibrosis Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Idiopathic Pulmonary Fibrosis Drug Consumption Market Share by Regions 2014-2019
Figure North America Idiopathic Pulmonary Fibrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Idiopathic Pulmonary Fibrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Idiopathic Pulmonary Fibrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Idiopathic Pulmonary Fibrosis Drug Production, Consumption Import and Export (K Pcs)
Figure China Idiopathic Pulmonary Fibrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Idiopathic Pulmonary Fibrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Idiopathic Pulmonary Fibrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Idiopathic Pulmonary Fibrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Idiopathic Pulmonary Fibrosis Drug Production, Consumption Import and Export (K Pcs)
Figure India Idiopathic Pulmonary Fibrosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Idiopathic Pulmonary Fibrosis Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Idiopathic Pulmonary Fibrosis Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Idiopathic Pulmonary Fibrosis Drug Market Share by Application (2014-2019)
Table Roche Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
Table Roche Idiopathic Pulmonary Fibrosis Drug Product Introduction, Application and Specification
Table Roche Idiopathic Pulmonary Fibrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Roche Idiopathic Pulmonary Fibrosis Drug Production Growth Rate (2014-2019)
Table Roche Idiopathic Pulmonary Fibrosis Drug Production Market Share (2014-2019)
Figure Roche Idiopathic Pulmonary Fibrosis Drug Revenue Market Share (2014-2019)
Table Roche Idiopathic Pulmonary Fibrosis Drug Main Business and Markets Served
Table Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
Table Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Drug Main Business and Markets Served
Table Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
Table Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Product Introduction, Application and Specification
Table Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Production Growth Rate (2014-2019)
Table Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Production Market Share (2014-2019)
Figure Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Revenue Market Share (2014-2019)
Table Beijing Continent Pharmaceutical Idiopathic Pulmonary Fibrosis Drug Main Business and Markets Served
Table Cipla Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
Table Cipla Idiopathic Pulmonary Fibrosis Drug Product Introduction, Application and Specification
Table Cipla Idiopathic Pulmonary Fibrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cipla Idiopathic Pulmonary Fibrosis Drug Production Growth Rate (2014-2019)
Table Cipla Idiopathic Pulmonary Fibrosis Drug Production Market Share (2014-2019)
Figure Cipla Idiopathic Pulmonary Fibrosis Drug Revenue Market Share (2014-2019)
Table Cipla Idiopathic Pulmonary Fibrosis Drug Main Business and Markets Served
Table Shionogi Idiopathic Pulmonary Fibrosis Drug Production Sites and Area Served
Table Shionogi Idiopathic Pulmonary Fibrosis Drug Product Introduction, Application and Specification
Table Shionogi Idiopathic Pulmonary Fibrosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Shionogi Idiopathic Pulmonary Fibrosis Drug Production Growth Rate (2014-2019)
Table Shionogi Idiopathic Pulmonary Fibrosis Drug Production Market Share (2014-2019)
Figure Shionogi Idiopathic Pulmonary Fibrosis Drug Revenue Market Share (2014-2019)
Table Shionogi Idiopathic Pulmonary Fibrosis Drug Main Business and Markets Served
Figure Global Idiopathic Pulmonary Fibrosis Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Idiopathic Pulmonary Fibrosis Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Idiopathic Pulmonary Fibrosis Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Idiopathic Pulmonary Fibrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Idiopathic Pulmonary Fibrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Idiopathic Pulmonary Fibrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Idiopathic Pulmonary Fibrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Idiopathic Pulmonary Fibrosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Idiopathic Pulmonary Fibrosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Idiopathic Pulmonary Fibrosis Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Idiopathic Pulmonary Fibrosis Drug by Application (2019-2025)
Table Idiopathic Pulmonary Fibrosis Drug Distributors List
Table Idiopathic Pulmonary Fibrosis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Roche、Boehringer Ingelheim、Beijing Continent Pharmaceutical、Cipla、Shionogi、

★調査レポート[世界の特発性肺線維症薬市場 2019年] (コード：DATA909X09542)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の特発性肺線維症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 特発性肺線維症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18557 / QYResearch / 2019年11月25日 / ※当調査レポートでは、特発性肺線維症治療の世界市場について調査・分析し、特発性肺線維症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物クラス、酸素療法、肺移植、その他）、用途別（病院、クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の特発性肺線維症治療市場動向 ・主要企業別マーケットシェア ・特発性肺線維症治療の種類別市場規模2014-2019 （薬物クラス、酸素療法、肺移植、その他） ・特発性肺線維症治療の用途別市場規模2014-2019 （病院、クリニック） ・特発性肺線維症治療の北米市場：主要企業・種類別/用途別市場規模 ・特発性肺線維症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. In 2018, the global Idiopathic Pulmonary Fibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Idiopathic Pulmonary Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Idiopathic Pulmonary Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South...
  • 世界の特発性低身長薬市場 2019年
    DATA909X09543 / QYResearch / 2019年11月20日 / ※本調査レポートは、特発性低身長薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BBT-031、MMP-0201、ソマトロピン、ソマトロピンS、その他に、用途別には、研究センター、病院、クリニックにセグメント区分し、特発性低身長薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・特発性低身長薬の世界市場概要 ・特発性低身長薬の製造コスト構成分析 ・特発性低身長薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・特発性低身長薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・特発性低身長薬のセグメント分析（種類別） （BBT-031、MMP-0201、ソマトロピン、ソマトロピンS、その他）...The global Idiopathic Short Stature Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Idiopathic Short Stature Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Idiopathic Short Stature Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Idiopathic Short Stature Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の多関節若年性特発性関節炎治療薬市場 2019年
    DATA909X13266 / QYResearch / 2019年11月20日 / ※本調査レポートは、多関節若年性特発性関節炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他に、用途別には、病院、診療所、その他にセグメント区分し、多関節若年性特発性関節炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多関節若年性特発性関節炎治療薬の世界市場概要 ・多関節若年性特発性関節炎治療薬の製造コスト構成分析 ・多関節若年性特発性関節炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多関節若年性特発性関節炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多関節若年性特発性関節炎治療薬のセグメント分析（種類別） （エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他）...The global Polyarticular Juvenile Idiopathic Arthritis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polyarticular Juvenile Idiopathic Arthritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polyarticular Juvenile Idiopathic Arthritis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polyarticular Juvenile Idiopathic Arthritis Drug in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の全身性特発性若年性関節炎の治療市場 2019年
    DATA909X16229 / QYResearch / 2019年11月20日 / ※本調査レポートは、全身性特発性若年性関節炎の治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他に、用途別には、クリニック、病院、その他にセグメント区分し、全身性特発性若年性関節炎の治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・全身性特発性若年性関節炎の治療の世界市場概要 ・全身性特発性若年性関節炎の治療の製造コスト構成分析 ・全身性特発性若年性関節炎の治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・全身性特発性若年性関節炎の治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・全身性特発性若年性関節炎の治療のセグメント分析（種類別） （アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）...The global Systemic Idiopathic Juvenile Arthritis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Systemic Idiopathic Juvenile Arthritis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Systemic Idiopathic Juvenile Arthritis Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Systemic Idiopathic Juvenile Arthritis Treatment in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の経カテーテル肺動脈弁(TPV)市場 2019年
    DATA909X16744 / QYResearch / 2019年11月22日 / ※本調査レポートは、経カテーテル肺動脈弁(TPV)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、バルブ、デリバリーシステムに、用途別には、病院、循環器センターにセグメント区分し、経カテーテル肺動脈弁(TPV)の世界市場を分析しました。 ・エグゼクティブ・サマリー ・経カテーテル肺動脈弁(TPV)の世界市場概要 ・経カテーテル肺動脈弁(TPV)の製造コスト構成分析 ・経カテーテル肺動脈弁(TPV)の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・経カテーテル肺動脈弁(TPV)の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・経カテーテル肺動脈弁(TPV)のセグメント分析（種類別） （バルブ、デリバリーシステム）...The global Transcatheter Pulmonary Valve (TPV) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Transcatheter Pulmonary Valve (TPV) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Pulmonary Valve (TPV) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Transcatheter Pulmonary Valve (TPV) in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の腎線維症治療市場 2019年
    DATA909X10187 / QYResearch / 2019年11月20日 / ※本調査レポートは、腎線維症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤に、用途別には、研究センター、病院、クリニックにセグメント区分し、腎線維症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・腎線維症治療の世界市場概要 ・腎線維症治療の製造コスト構成分析 ・腎線維症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・腎線維症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・腎線維症治療のセグメント分析（種類別） （アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤）...The global Kidney (Renal) Fibrosis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Kidney (Renal) Fibrosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Kidney (Renal) Fibrosis market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Kidney (Renal) Fibrosis in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆